Käännöksiä ei löytynyt valitulle kohdekielelle.
(pharmacology) A human monoclonal antibody targeted at interleukin-1 beta, intended to treat rheumatoid arthritis.
Ribbon diagram of canakinumab (blue) bound to IL-1β (yellow) from PDB entry 5bvp